News
-
-
PRESS RELEASE
EQS-Adhoc: Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028
Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028. The company intends to use the net proceeds for general corporate purposes -
-
PRESS RELEASE
EQS-Adhoc: Redcare Pharmacy N.V. launches EUR 300m convertible bonds and invites holders of its outstanding EUR 225m convertible bonds due 2028 to tender their bonds for cash
Redcare Pharmacy N.V. launches EUR 300m convertible bonds and offers to repurchase outstanding EUR 225m convertible bonds due 2028 for cash. The proceeds will be used for corporate purposes -
-
PRESS RELEASE
Redcare Pharmacy: fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million.
Redcare Pharmacy N.V. reports 28% fully-organic sales growth in Q1, with Rx sales in Germany up by 191% and active customers increasing by 0.6 million -
-
-
-
PRESS RELEASE
Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx.
Redcare Pharmacy N.V. reports a successful 2024 with strong growth, especially in Germany. Forecast for 2025 includes margin uplift and doubling of Rx sales, positioning the company as a market leader in multiple countries
